Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 2 |
2017 | 1 |
2019 | 1 |
2021 | 3 |
2022 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Identification of CD105 (endoglin) as novel risk marker in CLL.
Ann Hematol. 2022 Apr;101(4):773-780. doi: 10.1007/s00277-022-04756-4. Epub 2022 Jan 19.
Ann Hematol. 2022.
PMID: 35044512
Free PMC article.
Evaluation of biological activities of Barbarea integrifolia and isolation of a new glucosinolate derivated compound.
Badem M, Sener SO, Kanbolat S, Korkmaz N, Yildirmiş S, Ozgen U, Aliyazicioglu R, Salva E, Kaban K, Kandemir A, Calıs İ.
Badem M, et al. Among authors: kaban k.
Z Naturforsch C J Biosci. 2021 Apr 7;76(9-10):375-382. doi: 10.1515/znc-2020-0305. Print 2021 Sep 27.
Z Naturforsch C J Biosci. 2021.
PMID: 33823106
Item in Clipboard
Therapeutic Silencing of BCL-2 Using NK Cell-Derived Exosomes as a Novel Therapeutic Approach in Breast Cancer.
Kaban K, Hinterleitner C, Zhou Y, Salva E, Kantarci AG, Salih HR, Märklin M.
Kaban K, et al.
Cancers (Basel). 2021 May 15;13(10):2397. doi: 10.3390/cancers13102397.
Cancers (Basel). 2021.
PMID: 34063475
Free PMC article.
Item in Clipboard
Immunoprofiling of 4-1BB Expression Predicts Outcome in Chronic Lymphocytic Leukemia (CLL).
Kaban K, Greiner SM, Holzmayer S, Tandler C, Meyer S, Hinterleitner C, Salih HR, Märklin M, Heitmann JS.
Kaban K, et al.
Diagnostics (Basel). 2021 Nov 4;11(11):2041. doi: 10.3390/diagnostics11112041.
Diagnostics (Basel). 2021.
PMID: 34829391
Free PMC article.
Item in Clipboard
In Vitro Dose Studies on Chitosan Nanoplexes for microRNA Delivery in Breast Cancer Cells.
Kaban K, Salva E, Akbuga J.
Kaban K, et al.
Nucleic Acid Ther. 2017 Feb;27(1):45-55. doi: 10.1089/nat.2016.0633. Epub 2016 Oct 20.
Nucleic Acid Ther. 2017.
PMID: 27763825
Item in Clipboard
Modulation of the dual-faced effects of miR-141 with chitosan/miR-141 nanoplexes in breast cancer cells.
Kaban K, Salva E, Akbuga J.
Kaban K, et al.
J Gene Med. 2019 Sep;21(9):e3116. doi: 10.1002/jgm.3116. Epub 2019 Aug 22.
J Gene Med. 2019.
PMID: 31389101
Item in Clipboard
The effects of chitosan/miR-200c nanoplexes on different stages of cancers in breast cancer cell lines.
Kaban K, Salva E, Akbuga J.
Kaban K, et al.
Eur J Pharm Sci. 2016 Dec 1;95:103-110. doi: 10.1016/j.ejps.2016.05.030. Epub 2016 May 31.
Eur J Pharm Sci. 2016.
PMID: 27260087
No abstract available.
Item in Clipboard
Cite
Cite